FDA Orders Tobacco Company to Stop Sales of New Cigarettes

Share this content:
FDA Orders Tobacco Company to Stop Sales of New Cigarettes
FDA Orders Tobacco Company to Stop Sales of New Cigarettes

WEDNESDAY, Sept. 16, 2015 (HealthDay News) -- The U.S. Food and Drug Administration has ordered the R.J. Reynolds Tobacco Co. to stop selling four new cigarette brands because submissions for these products did not meet requirements set forth in the Federal Food, Drug, and Cosmetic Act, according to an announcement issued Sept. 15 by the agency.

The FDA determined that the cigarettes are substantially different from existing Reynolds tobacco products on the market and need a full agency review before they can be marketed. The cigarettes are Camel Crush Bold, Pall Mall Deep Set Recessed Filter, Pall Mall Deep Set Recessed Filter Menthol and Vantage Tech 13.

These new cigarettes contain higher levels of some ingredients and ingredients that were not in the comparison products, the agency said Tuesday. Camel Crush Bold, for example, contains a menthol capsule in its filter that the agency believes would make it more attractive to younger smokers.

"These products had been provisionally marketed while our scientific review has taken place," Mitch Zeller, J.D., director of the FDA's Center for Tobacco Products, explained during a morning news conference. But going forward, these products can no longer "be sold, distributed, imported or marketed in interstate commerce," Zeller said. Selling or distributing these brands could result in FDA enforcement action, including seizure, the agency said. Retail stores, however, have 30 days to dispose of any inventory on hand.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

FDA OKs Doptelet for Liver Dz Patients Undergoing ...

Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure

Slower Decline in Lung Function With Anthocyanin Intake

Slower Decline in Lung Function With Anthocyanin Intake

Slower annual rates of decline in FEV1 and FVC for those in highest quartile of anthocyanin intake

Bioengineering Feasible for Airway Reconstruction

Bioengineering Feasible for Airway Reconstruction

Bioengineered tracheal and bronchial reconstruction reported using stented aortic matrices

is free, fast, and customized just for you!

Already a member?

Sign In Now »